Drug Profile
Morphine rectal - CeNeS Pharmaceuticals
Alternative Names: MoraxenLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator University of Strathclyde
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Cancer pain
- Discontinued Postoperative pain
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 23 Jun 2008 CeNeS Pharmaceuticals has been acquired by PAION